Compositions and methods for treatment of hepatitis b

TW202627082APending Publication Date: 2026-07-01NAT TAIWAN UNIV +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114133537
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-09-02
Filing Date
2025-09-02
Publication Date
2026-07-01
Patent Text Reader

Abstract

The present invention is related to compositions and methods for modifying the hepatitis B virus (HBV) genome using CRISPR gene editing technology to treat a subject suffering from HBV. The present invention is also related to compositions of modified HBV genomes.
Need to check novelty before this filing date? Find Prior Art